CEACAM5 and cholangiocarcinoma: In this study, we retrospectively analyzed the preoperative serum CEA, CA125, and CA19-9 levels in 112 patients with cholangiocarcinoma who were treated in our center from 2011 to 2017 and explored their clinical value in determining the resectability of cholangiocarcinoma.